ARCHIVES

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

This article is from The Cancer Letter archive.

Vol. 16 No. 27 | July 6, 1990

Download PDF Visit The Full Archive

Related Articles

FDA Grants Orphan Designation To E7777 in T-Cell Lymphoma

August 30, 2013

NCI CTEP Approved Trials For the Month of December

December 27, 2013

Multivitamin Use Doesn’t Impact Outcomes, Study Finds

September 24, 2010

LAK/IL-2 Therapy Could Halt Kidney Cancer Deaths: DeVita

March 21, 1986

In Brief: Commerce Dept. Open Radiation Standards Facility For Mammography Calibration

April 4, 1996

In Brief: Carter Wants His Own Man, So Cooper Is Out; New Preventive Oncology Society Established

January 14, 1977